<DOC>
	<DOCNO>NCT00000297</DOCNO>
	<brief_summary>The purpose study investigate effect labetalol response intravenous nicotine</brief_summary>
	<brief_title>Effects Labetalol Nicotine Administration Humans - 14</brief_title>
	<detailed_description>The purpose study determine whether labetalol , alpha beta adrenergic blocker , block subjective physiological effect intravenously administer nicotine human . A total 12 subject participate double blind placebo control , outpatient study . Subjects 3 separate experimental session 3-9 day apart . On experimental session , single oral dose low ( 100mg ) high dose labetalol ( 200mg ) , placebo administer . Two hour labetalol placebo treatment , subject receive 15 variance gram nicotine base/kg intravenously . Several physiological endocrine subjective measure obtain session . We propose blockage adrenergic receptor labetalol significantly block physological subjective effect nicotine .</detailed_description>
	<mesh_term>Tobacco Use Disorder</mesh_term>
	<mesh_term>Nicotine</mesh_term>
	<mesh_term>Labetalol</mesh_term>
	<criteria>Male/Female , age 2155 year smoke history least 1 pack cigarette daily least 1 year . In good health verify medical history , screen examination , screen laboratory test . History heart disease , peripheral vascular disease , COPD , medical condition physician investigator deem inappropriate subject participation . Pregnant lactate use adequate birth control method . Use regular psychotropic medication ( antidepressant , antipsychotic , anxiolytic recent psychiatric history ) . Chronic use systemic steroid antihistamine . Abuse alcohol recreational prescription drug . Regular use tobacco product , include smokeless tobacco nicotine product .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>October 1998</verification_date>
</DOC>